REVECTINA (Ivermectin 6 mg tablet)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for REVECTINA (Ivermectin 6 mg tablet), covering 2017-06-02 to 2017-06-02. Get the full timeline:
Most recent: Clinical Trial Update: Bioavailability and Safety of Two Oral Fixed Dose Preparations Containing 18 mg Ivermectin (IVM 18 MG TABLETS, LICONSA S.A., Spain) Versus Reference Dosing (Weight Based) Containing 6 mg Ivermectin (REVECTINA®, Abbott Laboratórios do Brasil Ltda, Brazil) [Phase 1]